<p>梅薩實驗室（NASDAQ:MLAB - 獲取免費報告）在週一發佈的報告中被 Zacks Research 的投資分析師從 “強烈賣出” 評級上調至 “持有” 評級，Zacks.com 報道。</p>
<p>MLAB 還受到其他幾份研究報告的關注。華爾街 Zen 在 8 月 9 日的研究報告中將梅薩實驗室的股票評級從 “買入” 下調至 “持有”。富國銀行在 8 月 7 日的研究報告中將梅薩實驗室的股票評級從 “減持” 上調至 “持平”，並將該股票的目標價格從 100.00 美元下調至 67.00 美元。一位研究分析師對該股票給予了買入評級，另外兩位給予了持有評級。根據 MarketBeat 的數據，該公司目前的平均評級為 “持有”，平均目標價格為 113.50 美元。</p>
<p>獲取 <strong>梅薩實驗室</strong> 的提醒：</p>
<p><strong>獲取我們關於梅薩實驗室的最新股票報告</strong></p>
<h2>梅薩實驗室股票表現</h2>
<p>MLAB 股票在週一開盤價為 69.2550 美元。該公司的速動比率為 0.47，流動比率為 0.66，債務與股本比率為 0.46。梅薩實驗室的 52 周低點為 55.45 美元，52 周高點為 155.12 美元。該股票的市值為 3.809 億美元，市盈率為-494.68，貝塔值為 0.83。該公司的 50 日移動平均線為 82.73 美元，200 日移動平均線為 108.85 美元。</p>
<h2>梅薩實驗室的內部交易</h2>
<p>在其他新聞中，首席執行官 Gary M. Owens 在 6 月 16 日的交易中出售了 1,939 股公司的股票。股票以平均價格 97.12 美元出售，總交易額為 188,315.68 美元。交易後，首席執行官直接持有公司 45,824 股，價值 4,450,426.88 美元。此次交易使其持股減少了 4.06%。該出售在與 SEC 的法律文件中披露，相關信息可通過此鏈接獲取。此外，首席財務官 John Sakys 在 6 月 16 日的交易中出售了 642 股公司的股票。股票以平均價格 97.12 美元出售，總交易額為 62,351.04 美元。交易後，首席財務官持有公司 12,865 股，價值約 1,249,448.80 美元。此次交易使其持股減少了 4.75%。該出售的披露信息可在此找到。在過去的九十天裏，內部人士總共出售了價值 296,507 美元的 3,053 股公司股票。目前，4.90% 的股票由公司內部人士持有。</p>
<h2>機構資金流入和流出</h2>
<p>一些機構投資者和對沖基金最近對該公司的持倉進行了調整。懷俄明州在第一季度將其在梅薩實驗室的持股增加了 501.4%。懷俄明州現在擁有 427 股醫療儀器供應商的股票，價值 51,000 美元，此前在上個季度購買了 356 股。Quantbot Technologies LP 在第一季度購買了梅薩實驗室的新股份，價值約 67,000 美元。法國巴黎銀行金融市場在第二季度將其在梅薩實驗室的持股增加了 115.3%。法國巴黎銀行金融市場現在擁有 786 股醫療儀器供應商的股票，價值 74,000 美元，此前在上個季度購買了 421 股。Tower Research Capital LLC TRC 在第二季度將其在梅薩實驗室的持股增加了 432.9%。Tower Research Capital LLC TRC 現在擁有 842 股醫療儀器供應商的股票，價值 79,000 美元，此前在上個季度購買了 684 股。最後，US Bancorp DE 在第一季度將其在梅薩實驗室的持股增加了 48.3%。US Bancorp DE 現在擁有 1,323 股醫療儀器供應商的股票，價值 157,000 美元，此前在上個季度購買了 431 股。目前，90.60% 的股票由機構投資者和對沖基金持有。</p>
<h2>梅薩實驗室公司簡介</h2>
<p>（獲取免費報告）</p>
<p>梅薩實驗室公司在北美、歐洲、亞太地區及國際上開發、設計、製造、銷售和服務生命科學工具及質量控制產品和服務。滅菌和消毒控制部門提供生物、化學和清潔指示劑，用於評估製藥、醫療器械和醫療行業中滅菌、去污、消毒和清潔過程的有效性。</p>
<h2>特色文章</h2>
<ul>
<li>我們更看好的五隻股票比梅薩實驗室更好</li>
<li>FTSE 100 指數是什麼？</li>
<li>現在支持英特爾復甦的兩個強大力量</li>
<li>初學者如何閲讀股票圖表</li>
<li>阿徹的飛行里程碑和防禦勝利讓華爾街興奮</li>
<li>什麼是財報？</li>
<li>Upstart 股票可能會因短期擠壓而上漲</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在梅薩實驗室嗎？</h2>
<p>在你考慮梅薩實驗室之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而梅薩實驗室並不在名單上。</p>
<p>雖然梅薩實驗室目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

MLAB

<p>Zacks Research 將 Mesa Laboratories (NASDAQ:MLAB) 的評級從 “強烈賣出” 上調至 “持有”。其他分析師也調整了他們的評級，Wall Street Zen 將評級從 “買入” 下調至 “持有”，而富國銀行將其目標價從 100 美元下調至 67 美元。目前，MLAB 的平均評級為 “持有”，目標價為 113.50 美元。該股票開盤價為 69.26 美元，市值為 3.809 億美元。最近有內部人士出售股票的報告，機構持股比例為 90.60%</p>

<p>Mesa Laboratories (NASDAQ:MLAB - Get Free Report) was upgraded by investment analysts at Zacks Research from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a report issued on Monday,Zacks.com reports.</p>
<div class="lb-trans"><p>梅薩實驗室（NASDAQ:MLAB - 獲取免費報告）在週一發佈的報告中被 Zacks Research 的投資分析師從 “強烈賣出” 評級上調至 “持有” 評級，Zacks.com 報道。</p>
</div><p>MLAB has been the subject of several other research reports. Wall Street Zen cut shares of Mesa Laboratories from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Saturday, August 9th. Wells Fargo &amp; Company raised shares of Mesa Laboratories from an &#34;underweight&#34; rating to an &#34;equal weight&#34; rating and decreased their price objective for the stock from $100.00 to $67.00 in a research report on Thursday, August 7th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of &#34;Hold&#34; and an average target price of $113.50.</p>
<div class="lb-trans"><p>MLAB 還受到其他幾份研究報告的關注。華爾街 Zen 在 8 月 9 日的研究報告中將梅薩實驗室的股票評級從 “買入” 下調至 “持有”。富國銀行在 8 月 7 日的研究報告中將梅薩實驗室的股票評級從 “減持” 上調至 “持平”，並將該股票的目標價格從 100.00 美元下調至 67.00 美元。一位研究分析師對該股票給予了買入評級，另外兩位給予了持有評級。根據 MarketBeat 的數據，該公司目前的平均評級為 “持有”，平均目標價格為 113.50 美元。</p>
</div><p>Get <strong>Mesa Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>梅薩實驗室</strong> 的提醒：</p>
</div><p><strong>Get Our Latest Stock Report on Mesa Laboratories</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於梅薩實驗室的最新股票報告</strong></p>
</div><h2>Mesa Laboratories Stock Performance</h2>
<div class="lb-trans"><h2>梅薩實驗室股票表現</h2>
</div><p>Shares of MLAB stock opened at $69.2550 on Monday. The company has a quick ratio of 0.47, a current ratio of 0.66 and a debt-to-equity ratio of 0.46. Mesa Laboratories has a 52 week low of $55.45 and a 52 week high of $155.12. The stock has a market capitalization of $380.90 million, a PE ratio of -494.68 and a beta of 0.83. The firm has a 50 day moving average of $82.73 and a two-hundred day moving average of $108.85.</p>
<div class="lb-trans"><p>MLAB 股票在週一開盤價為 69.2550 美元。該公司的速動比率為 0.47，流動比率為 0.66，債務與股本比率為 0.46。梅薩實驗室的 52 周低點為 55.45 美元，52 周高點為 155.12 美元。該股票的市值為 3.809 億美元，市盈率為-494.68，貝塔值為 0.83。該公司的 50 日移動平均線為 82.73 美元，200 日移動平均線為 108.85 美元。</p>
</div><h2>Insider Transactions at Mesa Laboratories</h2>
<div class="lb-trans"><h2>梅薩實驗室的內部交易</h2>
</div><p>In other news, CEO Gary M. Owens sold 1,939 shares of the business's stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $97.12, for a total transaction of $188,315.68. Following the transaction, the chief executive officer directly owned 45,824 shares in the company, valued at $4,450,426.88. The trade was a 4.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO John Sakys sold 642 shares of the business's stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $97.12, for a total transaction of $62,351.04. Following the transaction, the chief financial officer owned 12,865 shares in the company, valued at approximately $1,249,448.80. This trade represents a 4.75% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 3,053 shares of company stock worth $296,507 over the last ninety days. 4.90% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他新聞中，首席執行官 Gary M. Owens 在 6 月 16 日的交易中出售了 1,939 股公司的股票。股票以平均價格 97.12 美元出售，總交易額為 188,315.68 美元。交易後，首席執行官直接持有公司 45,824 股，價值 4,450,426.88 美元。此次交易使其持股減少了 4.06%。該出售在與 SEC 的法律文件中披露，相關信息可通過此鏈接獲取。此外，首席財務官 John Sakys 在 6 月 16 日的交易中出售了 642 股公司的股票。股票以平均價格 97.12 美元出售，總交易額為 62,351.04 美元。交易後，首席財務官持有公司 12,865 股，價值約 1,249,448.80 美元。此次交易使其持股減少了 4.75%。該出售的披露信息可在此找到。在過去的九十天裏，內部人士總共出售了價值 296,507 美元的 3,053 股公司股票。目前，4.90% 的股票由公司內部人士持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>A number of institutional investors and hedge funds have recently made changes to their positions in the company. State of Wyoming boosted its holdings in Mesa Laboratories by 501.4% during the first quarter. State of Wyoming now owns 427 shares of the medical instruments supplier's stock worth $51,000 after buying an additional 356 shares in the last quarter. Quantbot Technologies LP purchased a new stake in Mesa Laboratories during the first quarter worth about $67,000. BNP Paribas Financial Markets boosted its holdings in Mesa Laboratories by 115.3% during the second quarter. BNP Paribas Financial Markets now owns 786 shares of the medical instruments supplier's stock worth $74,000 after buying an additional 421 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in Mesa Laboratories by 432.9% during the second quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier's stock worth $79,000 after buying an additional 684 shares in the last quarter. Finally, US Bancorp DE boosted its holdings in Mesa Laboratories by 48.3% during the first quarter. US Bancorp DE now owns 1,323 shares of the medical instruments supplier's stock worth $157,000 after buying an additional 431 shares in the last quarter. 90.60% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些機構投資者和對沖基金最近對該公司的持倉進行了調整。懷俄明州在第一季度將其在梅薩實驗室的持股增加了 501.4%。懷俄明州現在擁有 427 股醫療儀器供應商的股票，價值 51,000 美元，此前在上個季度購買了 356 股。Quantbot Technologies LP 在第一季度購買了梅薩實驗室的新股份，價值約 67,000 美元。法國巴黎銀行金融市場在第二季度將其在梅薩實驗室的持股增加了 115.3%。法國巴黎銀行金融市場現在擁有 786 股醫療儀器供應商的股票，價值 74,000 美元，此前在上個季度購買了 421 股。Tower Research Capital LLC TRC 在第二季度將其在梅薩實驗室的持股增加了 432.9%。Tower Research Capital LLC TRC 現在擁有 842 股醫療儀器供應商的股票，價值 79,000 美元，此前在上個季度購買了 684 股。最後，US Bancorp DE 在第一季度將其在梅薩實驗室的持股增加了 48.3%。US Bancorp DE 現在擁有 1,323 股醫療儀器供應商的股票，價值 157,000 美元，此前在上個季度購買了 431 股。目前，90.60% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Mesa Laboratories Company Profile</h2>
<div class="lb-trans"><h2>梅薩實驗室公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.</p>
<div class="lb-trans"><p>梅薩實驗室公司在北美、歐洲、亞太地區及國際上開發、設計、製造、銷售和服務生命科學工具及質量控制產品和服務。滅菌和消毒控制部門提供生物、化學和清潔指示劑，用於評估製藥、醫療器械和醫療行業中滅菌、去污、消毒和清潔過程的有效性。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Mesa Laboratories</li>
<li>What is the FTSE 100 index?</li>
<li>2 Powerful Forces Now Back Intel's Turnaround</li>
<li>How to Read Stock Charts for Beginners</li>
<li>Archer's Flight Milestones &amp; Defense Wins Excite Wall Street</li>
<li>What Are Earnings Reports?</li>
<li>Upstart Stock Could Pop on a Short Squeeze Soon</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比梅薩實驗室更好</li>
<li>FTSE 100 指數是什麼？</li>
<li>現在支持英特爾復甦的兩個強大力量</li>
<li>初學者如何閲讀股票圖表</li>
<li>阿徹的飛行里程碑和防禦勝利讓華爾街興奮</li>
<li>什麼是財報？</li>
<li>Upstart 股票可能會因短期擠壓而上漲</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Mesa Laboratories Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在梅薩實驗室嗎？</h2>
</div><p>Before you consider Mesa Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮梅薩實驗室之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mesa Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買...而梅薩實驗室並不在名單上。</p>
</div><p>While Mesa Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然梅薩實驗室目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Zacks 研究將 Mesa Laboratories（NASDAQ:MLAB）的評級上調至 “持有”